$CMS · CMS ENERGY CORP
CMS Energy filed its Q3 2026 10-Q, reporting net income available to common stockholders of $121M ($0.39 diluted EPS), down from $275M ($0.92) in Q3 2025. The decline was driven by a $525M impairment charge at NorthStar Clean Energy, the company's non-regulated renewables subsidiary. Consumers Energy, the regulated utility, posted net income of $391M vs $314M a year ago, benefiting from electric and gas rate increases. Revenue rose 8% to $2.183B.
- Q3 2026 net income available to common stockholders fell to $121M from $275M, a 56% decline YoY.
- Diluted EPS dropped to $0.39 vs $0.92 in Q3 2025, driven by a $525M NorthStar Clean Energy impairment charge.
- Consumers Energy (regulated utility) net income rose to $391M from $314M, supported by electric and gas rate increases.
- Nine-month net income fell to $576M from $775M, with EPS declining to $1.86 from $2.59.
- Operating revenue grew 8% YoY to $2.183B, but total operating expenses surged to $2.136B from $1.540B.
CMS shares are down 0.91% in regular trading to $68.95, a modest decline suggesting the NorthStar impairment was partially anticipated or viewed as non-recurring. The regulated utility's strong performance ($391M vs $314M) likely cushions the blow.
A $525M impairment at NorthStar Clean Energy turned what would have been a solid regulated-utility quarter into a 56% earnings collapse, raising questions about the non-regulated strategy.
CMS Energy's regulated utility (Consumers) delivered strong results with rate-increase tailwinds, consistent with peers benefiting from infrastructure investment recovery. The NorthStar Clean Energy impairment highlights the risk of non-regulated clean energy ventures within traditional utility holding companies.
NorthStar Clean Energy's $525M impairment and disposal costs signal ongoing losses in the non-regulated renewables segment, with additional $33M equity method investment impairment. The segment lost $193M in Q3 alone, threatening further write-downs if performance doesn't improve.